You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Dow
AstraZeneca
McKinsey
Johnson and Johnson
Harvard Business School

Last Updated: October 22, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Padsevonil

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Padsevonil?

Padsevonil is an investigational drug.

There have been 10 clinical trials for Padsevonil. The most recent clinical trial was a Phase 1 trial, which was initiated on January 18th 2019.

The most common disease conditions in clinical trials are Epilepsy, Seizures, and Drug Resistant Epilepsy. The leading clinical trial sponsors are UCB Biopharma S.P.R.L., UCB Biopharma SRL, and [disabled in preview].

There is one US patent protecting this investigational drug and thirty international patents.

Recent Clinical Trials for Padsevonil
TitleSponsorPhase
A Study to Test the Blood Concentration of 4 Padsevonil Product Variants and the Effect of Food on PadsevonilUCB Biopharma SRLPhase 1
A Study to Test the Safety, and Tolerability of Padsevonil in Healthy Male Japanese Study ParticipantsUCB Biopharma S.P.R.L.Phase 1
A Study to Test the Cardiac Effects of Padsevonil in Healthy Study ParticipantsUCB Biopharma S.P.R.L.Phase 1

See all Padsevonil clinical trials

Clinical Trial Summary for Padsevonil

Top disease conditions for Padsevonil
Top clinical trial sponsors for Padsevonil

See all Padsevonil clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
AstraZeneca
McKinsey
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.